Article Text

Download PDFPDF
Coexistence of late gadolinium enhancement due to myocardial infarction and hypertrophic cardiomyopathy
  1. David Lin1,
  2. John R Lesser1,
  3. Barry J Maron2
  1. 1Advanced Cardiac Imaging Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
  2. 2Hypertrophic Cardiomyopathy Center, Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA
  1. Correspondence to Barry J Maron, Minneapolis Heart Institute Foundation, 920 East 28th Street, Suite 300, Minneapolis, MN 55407, USA; hcm.maron{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Contrast-cardiovascular magnetic resonance (CMR) provides the opportunity to visualise myocardial fibrosis and scarring in vivo by virtue of late gadolinium enhancement (LGE) in atherosclerotic coronary artery disease (CAD), as well as in a variety of other structural cardiac diseases such as hypertrophic cardiomyopathy (HCM). However, LGE in CAD and HCM differ considerably with respect to location, pattern and often signal intensity.1 2 Recently, we have encountered a unique circumstance in which two patients each had CAD and prior myocardial infarction, as well as HCM. In both patients, independent areas of LGE were evident in the left ventricular …

View Full Text


  • Funding Supported in part by a grant from the Hearst Foundations, New York, NY.

  • Patient consent Obtained.

  • Ethics approval This study was conducted with the approval of the Minneapolis Heart Institute Foundation.

  • Provenance and peer review Not commissioned; not externally peer reviewed.